Literature DB >> 31200323

No survival difference between robotic and open radical hysterectomy for women with early-stage cervical cancer: results from a nationwide population-based cohort study.

Emilia Alfonzo1, Emelie Wallin2, Linnea Ekdahl3, Christian Staf4, Angelique Flöter Rådestad2, Petur Reynisson3, Karin Stålberg5, Henrik Falconer2, Jan Persson3, Pernilla Dahm-Kähler6.   

Abstract

PURPOSE: The aim of the study was to compare overall survival (OS) and disease-free survival (DFS) after open and robotic radical hysterectomy for early-stage cervical cancer. PATIENTS AND METHODS: This was a nationwide population-based cohort study on all women with cervical cancer stage IA1-IB of squamous, adenocarcinoma or adenosquamous histological subtypes, from January 2011 to December 2017, for whom radical hysterectomy was performed. The Swedish Quality Register of Gynaecologic Cancer was used for identification. To ensure quality and conformity of data and to disclose patients not yet registered, hospital registries were reviewed and validated. Cox and propensity score regression analysis and univariable and multivariable regression analysis were performed in regard to OS and DFS.
RESULTS: There were 864 women (236 open and 628 robotic) included in the study. The 5-year OS was 92% and 94% and DFS was 84% and 88% for the open and robotic cohorts, respectively. The recurrence pattern was similar in both groups. Using propensity score analysis and matched cohorts of 232 women in each surgical group, no significant differences were seen in survival: 5-year OS of 92% in both groups (hazard ratio [HR], 1.00; 95% confidence interval [CI], 0.50-2.01) and DFS of 85% vs 84% in the open and robotic cohort, respectively (HR, 1.08; 95% CI, 0.66-1.78). In univariable and multivariable analysis with OS as the end-point, no significant factors were found, and in regard to DFS, tumour size (p < 0.001) and grade 3 (p = 0.02) were found as independent significant risk factors.
CONCLUSION: In a complete nationwide population-based cohort, where radical hysterectomy for early-stage cervical cancer is highly centralised, neither long-term survival nor pattern of recurrence differed significantly between open and robotic surgery.
Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Cervical cancer; Disease-free survival; Radical hysterectomy; Robotic; Surgery; Survival

Mesh:

Year:  2019        PMID: 31200323     DOI: 10.1016/j.ejca.2019.05.016

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  22 in total

1.  Survival After Minimally Invasive vs Open Radical Hysterectomy for Early-Stage Cervical Cancer: A Systematic Review and Meta-analysis.

Authors:  Roni Nitecki; Pedro T Ramirez; Michael Frumovitz; Kate J Krause; Ana I Tergas; Jason D Wright; J Alejandro Rauh-Hain; Alexander Melamed
Journal:  JAMA Oncol       Date:  2020-07-01       Impact factor: 31.777

2.  Minimally invasive radical hysterectomy for early-stage cervical cancer: Volume-outcome relationship in the early experience period.

Authors:  Koji Matsuo; Shinya Matsuzaki; Rachel S Mandelbaum; Erica J Chang; Maximilian Klar; Kazuhide Matsushima; Brendan H Grubbs; Lynda D Roman; Jason D Wright
Journal:  Gynecol Oncol       Date:  2020-05-27       Impact factor: 5.482

3.  Minimally invasive surgery versus laparotomy for radical hysterectomy in the management of early-stage cervical cancer: Survival outcomes.

Authors:  Benny Brandt; Vasileios Sioulas; Derman Basaran; Theresa Kuhn; Katherine LaVigne; Ginger J Gardner; Yukio Sonoda; Dennis S Chi; Kara C Long Roche; Jennifer J Mueller; Elizabeth L Jewell; Vance A Broach; Oliver Zivanovic; Nadeem R Abu-Rustum; Mario M Leitao
Journal:  Gynecol Oncol       Date:  2020-01-07       Impact factor: 5.482

Review 4.  Radical Hysterectomy for Cervical Cancer: the Right Surgical Approach.

Authors:  Benny Brandt; Gabriel Levin; Mario M Leitao
Journal:  Curr Treat Options Oncol       Date:  2022-02-15

5.  Open Versus Minimally Invasive Radical Hysterectomy in Cervical Cancer: The CIRCOL Group Study.

Authors:  Glauco Baiocchi; Reitan Ribeiro; Ricardo Dos Reis; Deraldo Fernando Falcao; Andre Lopes; Ronaldo Lucio Rangel Costa; Gabriel Lowndes Souza Pinto; Marcelo Vieira; Lillian Yuri Kumagai; Carlos Chaves Faloppa; Henrique Mantoan; Levon Badiglian-Filho; Audrey Tieko Tsunoda; Tariane Friedrich Foiato; Carlos Eduardo Mattos Cunha Andrade; Leonardo Oliveira Palmeira; Bruna Tirapelli Gonçalves; Paulo Henrique Zanvettor
Journal:  Ann Surg Oncol       Date:  2021-09-20       Impact factor: 5.344

6.  Differences in the Impact of Heart Rate Variability on the Surgical Approach in Patients With Early Cervical Cancer: Laparoscopic versus Open Surgery.

Authors:  Jian Liu; Jingfeng Wang; Zhaoya Deng; Shiqi Liu; Guangqiao Li; Yilin Sun; Longfei Gao; Chenghui Li; Bo Shi
Journal:  Front Oncol       Date:  2022-06-03       Impact factor: 5.738

7.  Time to accept a new old standard of care in cervical cancer.

Authors:  Roni Nitecki; Alexander Melamed
Journal:  Int J Gynecol Cancer       Date:  2020-08-12       Impact factor: 4.661

Review 8.  Cervical Cancer Surgery: Current State of Affairs.

Authors:  Fan Chun Yang; Wei Huang; Weihong Yang; Jie Liu; Guihai Ai; Ning Luo; Jing Guo; Peng Teng Chua; Zhongping Cheng
Journal:  Gynecol Minim Invasive Ther       Date:  2021-04-30

9.  Laparoscopic Radical Hysterectomy Results in Higher Recurrence Rate Versus Open Abdominal Surgery for Stage IB1 Cervical Cancer Patients With Tumor Size Less Than 2 Centimeter: A Retrospective Propensity Score-Matched Study.

Authors:  Xiaoyue Chen; Jiangtao Yu; Hongqin Zhao; Yan Hu; Haiyan Zhu
Journal:  Front Oncol       Date:  2021-06-10       Impact factor: 6.244

10.  Survival Outcomes in Patients With 2018 FIGO Stage IA2-IIA2 Cervical Cancer Treated With Laparoscopic Versus Open Radical Hysterectomy: A Propensity Score-Weighting Analysis.

Authors:  Wancheng Zhao; Yunyun Xiao; Wei Zhao; Qing Yang; Fangfang Bi
Journal:  Front Oncol       Date:  2021-06-17       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.